Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Dermatitis atopic

Not yet recruiting

Investigational

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Img-007

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Study to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:HUMANISED IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST THYMIC STROMAL LYMPHOPOIETIN

Contact Research Centre

Diffuse large B-cell lymphoma+7

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Cytarabine, Tafasitamab, and Lenalidomide for Patients with Relapsed Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Obesity

Not recruiting

Registered drug

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:HRS 9531

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Cardiovascular disorder

Not recruiting

Investigational

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Registered drug

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Systemic scleroderma

Not recruiting

Investigational

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Find therapies in clinical trials near you – page 3

67 trials match your criteria

Dermatitis atopic

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Plasma cell myeloma

Ramantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant

Dermatitis atopic

Study to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis

Diffuse large B-cell lymphoma+7

Study on the Effectiveness and Safety of Cytarabine, Tafasitamab, and Lenalidomide for Patients with Relapsed Diffuse Large B-Cell Lymphoma

Obesity

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Dermatitis atopic

A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

Cardiovascular disorder

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Type 2 diabetes mellitus+3

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Dermatitis atopic

A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis

Systemic scleroderma

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Dermatitis atopic

A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

Dermatitis atopic

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.